This article was initiated, developed and funded by Merck

Sponsored feature: Highlights from the National Epilepsy Nurse Meeting

STADA Australia continues to innovate in Parkinson’s Disease with MOVAPO® pre-filled syringes (PFS) Parkinson’s Disease is a surprisingly prevalent condition with an estimated 10 million people worldwide and roughly 70,000 Australians (1 in every 340 people) suffering from the condition.1 It is the second most prevalent neurological condition exceeded only by dementia. It is more common […]

News from the recent ILAE meeting

Summary Perampanel has a novel mode of action based on a rational hypothesis of seizure initiation and spread. This can be considered when discussing the possibility of initiating perampanel treatment in patients with partial onset seizures who have failed to gain control with other AEDs. Perampanel is an easy to use antiepileptic treatment that, based […]